Literature DB >> 30285529

What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials?

Katherine V Ferry-Galow1, Vivekananda Datta1, Hala R Makhlouf1, John Wright1, Bradford J Wood1, Elliot Levy1, Etta D Pisano1, Alda L Tam1, Susanna I Lee1, Umar Mahmood1, Lawrence V Rubinstein1, James H Doroshow1, Alice P Chen1.   

Abstract

PURPOSE: : Research biopsy specimens collected in clinical trials often present requirements beyond those of tumor biopsy specimens collected for diagnostic purposes. Research biopsies underpin hypothesis-driven drug development, pharmacodynamic assessment of molecularly targeted anticancer agents, and, increasingly, genomic assessment for precision medicine; insufficient biopsy specimen quality or quantity therefore compromises the scientific value of a study and the resources devoted to it, as well as each patient's contribution to and potential benefit from a clinical trial.
METHODS: : To improve research biopsy specimen quality, we consulted with other translational oncology teams and reviewed current best practices.
RESULTS: : Among the recommendations were improving communication between oncologists and interventional radiologists, providing feedback on specimen sufficiency, increasing academic recognition and financial support for the time investment required by radiologists to collect and preserve research biopsy specimens, and improving real-time assessment of tissue quality.
CONCLUSION: : Implementing these recommendations at the National Cancer Institute's Developmental Therapeutics Clinic has demonstrably improved the quality of biopsy specimens collected; more widespread dissemination of these recommendations beyond large clinical cancer centers is possible and will be of value to the community in improving clinical research and, ultimately, patient care.

Entities:  

Year:  2018        PMID: 30285529      PMCID: PMC6237512          DOI: 10.1200/JOP.18.00092

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  28 in total

1.  Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V.

Authors:  E D Pisano; L L Fajardo; D J Caudry; N Sneige; W J Frable; W A Berg; I Tocino; S J Schnitt; J L Connolly; C A Gatsonis; B J McNeil
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

2.  Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.

Authors:  I O Ellis; S Humphreys; M Michell; S E Pinder; C A Wells; H D Zakhour
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

3.  Quality improvement guidelines for percutaneous needle biopsy.

Authors:  Sanjay Gupta; Michael J Wallace; John F Cardella; Sanjoy Kundu; Donald L Miller; Steven C Rose
Journal:  J Vasc Interv Radiol       Date:  2010-03-20       Impact factor: 3.464

4.  Application of molecular profiling in clinical trials for advanced metastatic cancers.

Authors:  Shivaani Kummar; P Mickey Williams; Chih-Jian Lih; Eric C Polley; Alice P Chen; Larry V Rubinstein; Yingdong Zhao; Richard M Simon; Barbara A Conley; James H Doroshow
Journal:  J Natl Cancer Inst       Date:  2015-02-06       Impact factor: 13.506

5.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Baris Turkbey; Arvin K George; Jason Rothwax; Nabeel Shakir; Chinonyerem Okoro; Dima Raskolnikov; Howard L Parnes; W Marston Linehan; Maria J Merino; Richard M Simon; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

6.  Validation of a hypoxia-inducible factor-1 alpha specimen collection procedure and quantitative enzyme-linked immunosorbent assay in solid tumor tissues.

Authors:  Sook Ryun Park; Robert J Kinders; Sonny Khin; Melinda Hollingshead; Smitha Antony; Ralph E Parchment; Joseph E Tomaszewski; Shivaani Kummar; James H Doroshow
Journal:  Anal Biochem       Date:  2014-05-04       Impact factor: 3.365

7.  Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.

Authors:  Zuanel Diaz; Adriana Aguilar-Mahecha; Eric R Paquet; Mark Basik; Michèle Orain; Errol Camlioglu; André Constantin; Naciba Benlimame; Dimcho Bachvarov; Guillaume Jannot; Martin J Simard; Benoit Chabot; Adrian Gologan; Roscoe Klinck; Thérèse Gagnon-Kugler; Bernard Lespérance; Benoit Samson; Petr Kavan; Thierry Alcindor; Richard Dalfen; Cathy Lan; Catherine Chabot; Marguerite Buchanan; Ewa Przybytkowski; Samia Qureshi; Caroline Rousseau; Alan Spatz; Bernard Têtu; Gerald Batist
Journal:  Mod Pathol       Date:  2013-06-07       Impact factor: 7.842

8.  Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.

Authors:  Alda L Tam; Edward S Kim; J Jack Lee; Joe E Ensor; Marshall E Hicks; Ximing Tang; George R Blumenschein; Christine M Alden; Jeremy J Erasmus; Anne Tsao; Scott M Lippman; Waun K Hong; Ignacio I Wistuba; Sanjay Gupta
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

9.  Use of research biopsies in clinical trials: are risks and benefits adequately discussed?

Authors:  Michael J Overman; Janhavi Modak; Scott Kopetz; Ravi Murthy; James C Yao; Marshall E Hicks; James L Abbruzzese; Alda L Tam
Journal:  J Clin Oncol       Date:  2012-11-05       Impact factor: 44.544

10.  Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use.

Authors:  Apurva K Srivastava; Soumya Jaganathan; Laurie Stephen; Melinda G Hollingshead; Adam Layhee; Eric Damour; Jeevan Prasaad Govindharajulu; Jennifer Donohue; Dominic Esposito; James P Mapes; Robert J Kinders; Naoko Takebe; Joseph E Tomaszewski; Shivaani Kummar; James H Doroshow; Ralph E Parchment
Journal:  Clin Cancer Res       Date:  2015-10-07       Impact factor: 12.531

View more
  13 in total

1.  State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.

Authors:  Elliot B Levy; Maria I Fiel; Stanley R Hamilton; David E Kleiner; Shannon J McCall; Peter Schirmacher; William Travis; Michael D Kuo; Robert D Suh; Alda L Tam; Shaheen U Islam; Katherine Ferry-Galow; Rebecca A Enos; James H Doroshow; Hala R Makhlouf
Journal:  J Clin Oncol       Date:  2020-03-05       Impact factor: 44.544

2.  The use of research biopsies in oncology trials: challenges and controversies.

Authors:  Katherine V Ferry-Galow; Alice P Chen
Journal:  J Hosp Manag Health Policy       Date:  2019-04-01

3.  Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens.

Authors:  Mingxuan Xu; Coya Tapia; Joud Hajjar; Sharjeel Sabir; Rivka Colen; Priyadharsini Nagarajan; Phyu P Aung; Jing Gong; Jordi Rodon; Siqing Fu; Bettzy Stephen; Sinchita Roy-Chowdhuri; Hung Le; Vincent Yang; Abdulrazzak Zarifa; Mohamed Elsayed Abdelsalam; Anuja Jhingran; Milind Javle; Shubham Pant; Brett Carter; Denai R Milton; Ryan Sun; Daniel D Karp; Eugene Jon Koay; Yali Yang; Ignacio I Wistuba; Patrick Hwu; Funda Meric-Bernstam; Aung Naing
Journal:  J Immunother Precis Oncol       Date:  2021-05-14

4.  Rapid non-destructive volumetric tumor yield assessment in fresh lung core needle biopsies using polarization sensitive optical coherence tomography.

Authors:  Sreyankar Nandy; Timothy L Helland; Benjamin W Roop; Rebecca A Raphaely; Amy Ly; Madelyn Lew; Sarita R Berigei; Martin Villiger; Anastasia Sorokina; Margit V Szabari; Florian J Fintelmann; Melissa J Suter; Lida P Hariri
Journal:  Biomed Opt Express       Date:  2021-08-13       Impact factor: 3.732

5.  Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center.

Authors:  Kyoungmin Lee; So Jung Lee; Shinkyo Yoon; Baek-Yeol Ryoo; Sang-We Kim; Sang Hyun Choi; Sang Min Lee; Eun Jin Chae; Yangsoon Park; Se-Jin Jang; Soo-Yeon Park; Young-Kwang Yoon; Seong Ho Park; Tae Won Kim
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

6.  Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial.

Authors:  Alice P Chen; Shivaani Kummar; Nancy Moore; Lawrence V Rubinstein; Yingdong Zhao; P Mickey Williams; Alida Palmisano; David Sims; Geraldine O'Sullivan Coyne; Christina L Rosenberger; Mel Simpson; Kanwal P S Raghav; Funda Meric-Bernstam; Stephen Leong; Saiama Waqar; Jared C Foster; Mariam M Konaté; Biswajit Das; Chris Karlovich; Chih-Jian Lih; Eric Polley; Richard Simon; Ming-Chung Li; Richard Piekarz; James H Doroshow
Journal:  JCO Precis Oncol       Date:  2021-01-12

7.  Variability in biopsy quality informs translational research applications in hepatocellular carcinoma.

Authors:  Kelley Weinfurtner; Joshua Cho; Daniel Ackerman; James X Chen; Abashai Woodard; Wuyan Li; David Ostrowski; Michael C Soulen; Mandeep Dagli; Susan Shamimi-Noori; Jeffrey Mondschein; Deepak Sudheendra; S William Stavropoulos; Shilpa Reddy; Jonas Redmond; Tamim Khaddash; Darshana Jhala; Evan S Siegelman; Emma E Furth; Stephen J Hunt; Gregory J Nadolski; David E Kaplan; Terence P F Gade
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.996

8.  T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis.

Authors:  Laura Brennan; Jurriaan Brouwer-Visser; Eveline Nüesch; Maria Karpova; Astrid Heller; Fabien Gaire; Meike Schneider; Bruno Gomes; Konstanty Korski
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

Review 9.  The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.

Authors:  Henry Rodriguez; Jean Claude Zenklusen; Louis M Staudt; James H Doroshow; Douglas R Lowy
Journal:  Cell       Date:  2021-04-01       Impact factor: 41.582

Review 10.  Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach.

Authors:  May T Cho; Sepideh Gholami; Dorina Gui; Sooraj L Tejaswi; Ghaneh Fananapazir; Nadine Abi-Jaoudeh; Zeljka Jutric; Jason B Samarasena; Xiaodong Li; Jennifer B Valerin; Jacob Mercer; Farshid Dayyani
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.